References
- 1. Yordanov M, Ananiev Yu, Minkova V, Todorov T. Morphological characteristics of patients with focal and segmental sclerosis. Nephrology, dialysis, transplantation, 2020, 20 (4): 42-49.
- 2. Arias LF, Jimenez CA, Arroyave MA. Histologic variants of primary focal segmental glomerulosclerosis: presentation and outcome. J Bras Nefrol 2013,35(2):48-53.
- 3. Arias LF, Henao J, Giraldo RD et al. Glomerular diseases in Hispanic population: review of regional renal biopsy database. Sao Paulo Med J, 2009,127-140.
- 4. Beaudreuil S, Durrbach A. La hyalinose segmentaire et focale. Bull Acad Natle Med, 2017,201 :47-69.
- 5. Choi J. Histologic classification of FSFS:Does form delineate function. Clin J Am Soc Nephrol 2013,8:344-346.
- 6. D'Agati V, Alster JM, Jennette JC et al. Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol, 2013,8(3):399-406.
- 7. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004,43:368–382.
- 8. Das P, Sharma A, Gupta R et al. Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features. Saudi J Kidney Dis Transpl, 2012,23(5): 1008-1016.
- 9. Deegens JK, Steenbergan EJ, Borm GF, Wetzels JF. Pathological variants of focal segmental glomerulosclerosisin adult Dutch population-epidemiology and outcome. Nephrol Dial Transplant 2008,23: 186-192.
- 10. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United Statws. AmJ Kidney Dis, 2004,43:815-825.
- 11. Kriz W, Le Hir M. Patwhays to nephron loss starting from glomerular disease-insights from animal models. Kidney Int. 2005, 67: 404-419.
- 12. Meehan SM, Chang A, Gibson IW et al. A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis. Virchows Arch, 2013, 462: 229–232.
- 13. Meliambro K, Schvartzman M, Cravedi P, Campbell KN. The impact of histologic variants of FSGS outcome. Hindawi J, 2014, https://doi.org/10=1155/2014/913690
- 14. Polito MG, de Moura LA, Kirsztajn GM. An overview on frecancy of renal biopsy diagnosis in Brazil& clinical and pathological patterns based on 9617 native kidney biopsies. Nephrol Dial Transplant, 2010,25: 490-496.
- 15. Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol, 2017, 12:1-16.
- 16. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol, 2003, 14: 2958-2966.
- 17. Silverstein DM, Craver R. Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol, 2007, 2: 700-707.
- 18. Stokes MB, Markowitz GS, Lan J et al. Glomerular tip lesion:a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 2004, 65:1690-1702.
- 19. Stokes MB, D’Agati VD. Morphologic variants of focal segmental glomerulosclerosis and their significance. Adv Chronic Kidney Dis, 2014, 21: 400-407.
- 20. Valeri MB, Markowitz AM, D`Agati GS. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int, 2006,70:1783-1792.
- 21. Thomas DB, Franceschini N, Hogan SL. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int, 2006, 69: 920-926.